In seminar, Tom Lynch talks drug development and improving patient outcomes

Lynch is the former director of Yale Cancer Center and current chief scientific officer at Bristol-Myers Squibb. His talk was presented by the Blavatnik Fund.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news